Abstract PDZ motifs are small protein-protein interaction modules that are thought to play a role in the clustering of submem bra nous signalling molecules. The specificity and func tional consequences of their associative actions is still largely unknown. Using two-hybrid methodology we here demonstrate that the PDZ motif of neuronal nitric oxide synthase (nNOS) can mediate the binding to several other proteins in brain. Peptide library screening showed that proteins bearing a carboxy-terminal G(D,E)XV* sequence are preferred targets for the nNOS amino-terminal PDZ motif. Potential nNOS targets include a melanoma-associated antigen, cyclophilins and the alC-adrenergic receptor.
Introduction
Protein-protein interactions are the crucial events in cellu la r signaling mechanisms and are in many cases mediated via relatively small protein domains. The importance of such de fined binding modules came with the recognition of the SH2 a n d SH3 (src homology) motifs which were later shown to be very specific binding domains for phosphotyrosine-containing peptides and proline-rich stretches [1] . Later, the PH (pleckstrin homology), LIM (Lin-ll/lsl-l/Mec-3) and PTB (phosphotyrosine-binding) domain have been added to this list [1] [2] [3] [4] [5] . Most recently, the PDZ motif was recognized as a pro tein-binding module in proteins involved in submembranous signaling processes [6] [7] [8] [9] [10] [11] [12] [13] , This 90 amino acid sequence motif w a s first called GLGF repeat, later renamed to DHR (for Discs-large Homologous Region) and only recently termed P D Z motif (acronym of PSD-95/SAP90, a constituent of syn ap tic junctions, the Drosophila discs-large tumor suppressor gene product Dig A, present in septate junctions, and ZO-1, th e major protein component of tight junctions) [14] [15] [16] [17] . The m otif was suggested to play a role in targeting the protein to th e submembranous cytoskeleton or in regulating the intrinsic activity of the enzyme [18] . Currently, more than 50 different proteins are known to contain PDZ motifs [14, 19, 20] . Most of :hese proteins are involved in signal transduction events or Organization of cytoskeletal structures, all at or close to the Dlasma membrane.
Other demonstrations of protein-protein interactions that are mediated by PDZ motifs have appeared recently. Several investigations reported on the recognition of a carboxy-terminal T/SXV* motif (where T is threonine, S is serine, X is any amino acid, V is valine, and the asterisk symbolizes the car boxyl end of the protein) by the PDZ domains in multiple members of the PSD-95/SAP90 family of membrane-associ ated guanylate kinases, MAGUKs [8, 9, 11] . The T/SXV* motif is found in a diverse series of receptor and channel proteins suggesting that PDZ-containing proteins may be widely in volved in membrane specialization by anchoring signaling molecules at specific subcellular sites [15, 17] . The in vivo rele vance is evident form InctD, a PDZ-containing protein that is essential for negative feedback regulation of the light-acti vated signaling cascade in Drosophila photoreceptors by bind ing the TRP Ca2+ channel [6] , Also, the carboxy-terminus of the adenomatous polyposis coli gene product APC was shown to be recognized by the second PDZ domain of the human homolog of the Drosophila tumor suppressor discs-large [13] . The X-ray crystallographic structure of the third PDZ mo tifs of hDlg alone and PSD-95 provided the basis for under standing the recognition of the T/SXV* carboxyterminal pep tide [21, 22] . The peptide binds in a short groove on the surface of the PDZ motif and a prominent cavity, formed by conserved residues in the PDZ motif, stabilizes the carboxylate moiety [21] , In addition, another mode of interaction by PDZ motifs was observed for hDlg PDZ-3; the domain forms a dimer in the crystal albeit that this interaction in solution appeared rather weak [22] , Neuronal nitric oxide synthase (nNOS) differs from the two other NOS family members (endothelial NOS and macro phage NOS) in having an N-terminal segment that harbors a PDZ motif [18] and it has been proposed that this single PDZ motif is responsible for the membrane targeting of nNOS [23] . Indeed it has been demonstrated that its N-terminal PDZ mo tif determines nNOS association with the sarcolemma in muscle through binding to the dystrophin complex [10] . In brain the submembranous localization of nNOS was inde pendent of the dystrophin complex [10] . To identify the pro tein-binding sites for the nNOS PDZ motif in brain tissue we used two-hybrid interaction trap methodology [24] . The con sensus sequence for carboxy-terminal peptides that are prefer entially bound by the nNOS PDZ motif was determined and used to predict potential nNOS-associated proteins in brain. encoding protein fused to the transcription activation domain, and lacZ reporter plasmid were introduced into yeast strain EGY48 by transformation. Interaction was tested on minimal agar plates lacking leucine, tryptophan, uracil and histidine, and containing 2% galactose, 1% rafiinose and 80 pg/ml X-gal [24] .
Materials and methods

Interaction-trap assay
Generation of nNOS subclones
The full-length rat nNOS cDNA, cloned in plasmid pBluescript KS, was a gift o f Dr. Snyder (Baltimore, MD). The insert o f subclone nNOS(aa 1-111) was generated by the polymerase chain reaction (PCR) using oligonucleotide primers nosl (5'-TTGAATTCTGAAG-GACAC AGAT ACC AT-3') and nos2 (5'-TAAGATCTGAAGGTG-GT CT CC AG AT G-3'). The amplified product was bhmt-ended with Klenow (large fragment) D N A polymerase and subcloned in pEG202 vector. Subclone nNOS(aa 1-195) is the product o f the amplification with primers nosl and nos3 (5'-TTTCTCGAGCATCATGTTCCCC-GATGT-3'). After digestion with iTctfRi, this fragment was bluntended with Klenow, digested with Xhol and also subcloned in pEG202 vector. The fragment nNOS(aa 99-418) that is missing the PDZ motif was excised from pBlue-nNOS using Apcil and UtiwHI restriction enzymes» blunt-ended and subcloned in pEG202.
Generation of PSD-951SAP90, Fas and alC-adrenergic receptor
sub clones Total RNA was isolated using the LiCl/urea method [25] . SAP90 cD N A fragment was generated by reverse transcriptase (RT)-PCR as described [26] . Specific oligonucleotide primers SAP90-1 (5'-CCA-GATCTGCAGTGGAGGCCC-3') and SAP90-2 (5'-AGGCTCGAG-GTCCTTGGCCAC-3') were deduced from the published sequence [27] . The amplification product was digested with BgUl and Xhol and subcloned in plasmid pJGBr2 (a modified prey vector) and a pEG202-derived bait vector.
Prey plasmid pJG-hFas was constructed by subcloning a bluntended Bglll-Apal fragment derived from pCMV-hFas (kindly pro vided by Dr. P. Anderson, Boston, MA) into the pJGBr2 interaction trap prey vector.
A cD N A fragment encoding the last 114 amino acid residues o f the rat alC-adrenergic receptor [28] was generated by reverse transcrip tase (RT)-PCR [26] using oligonucleotide primers alCAR-1 (5'-GGAATTCAAGCATGCCCTGGG-3') and alC A R -2 (5'-ATACTC-GAGCTAGACTTCCTCCCCGTT-3'). The PCR product was di gested with £coRI and Xhol and subcloned in the prey vector p JG4-5.
Construction of peptide library
The sequences of the oligonucleotides used in the generation of the peptide library are 5'-CCGGATCC(NNB)2oCGAATTCC-3' (where N is a mixture of A, G, C and T and B a mixture of G, T and C) and 5'-GGAATTCG~3' (for antisense priming). The primers were annealed at room temperature and filled in using Klenow (large frag ment) D N A polymerase in the presence of 0.1 mM o f each dNTP. After removal of unincorporated nucleotides and primers, the ampli fied product was digested with BamHl and EcoRl. After size-separation on 4% NuSieve GTG agarose (FMC) the product was recovered from the agarose using Gelase (Biozym) and then precipitated. Sub sequently, the fragments were ligated in JBg/II-iscflRI-digested pJGBr2 prey vector, transferred to TG-1 cells by electroporation and plated on TYE/glucose plates. The resulting library contained 8 X 10a inde pendent transformants of which 95% contained the peptide-encoding insert. Colonies on the plates were collected by scraping and plasmid D N A was isolated using the Qiagen plasmid Mega Kit (Westburg).
DNA sequence analysis
Nucleotide sequences were determined by the double-stranded D N A dideoxy sequencing method using radioactive nucleotides [29] or by cycle sequencing employing fluorochrome-tagged primers ac cording to the manufacturer's instructions (Amersham, U K ). D N A sequence gel readings were analyzed using the G CG package 
Results
In muscle tissue nNOS can be targeted to the dystrophin glycoprotein complex on the sarcolemma by virtue of its PDZ motif [10] , In brain, a dystrophin glycoprotein complex is absent but still nNOS is localized submembranously [10] sug gestive of other nNOS targets in brain. Reasoning that the nNOS PDZ motif was responsible for the subcellular distri bution [23] we set out to clone the nNOS PDZ motif targets in brain using the two-hybrid interaction trap methodology [24] , To this end, the rat nNOS PDZ motif (amino acids 1-111) as fused to the LexA DNA-binding domain and used as a bait to screen a human fetal brain cDNA library. Several interacting clones were obtained from 10G transfected yeast colonies and for most cDNAs the interaction could be confirmed after reintroduction of the involved plasmids in yeast. Subsequently, end~in sequencing of the isolated interacting cDNAs was per formed to enable screening of the nucleotide sequence data bases for possible homologies to known genes. The results are summarized in ' Table 1 . Five clones appeared identical or homologous to expressed sequence tags (EST), database en tries . for which no functional data at the protein level are available. Also, two independent but overlapping cDNAs were isolated that encode a thyroid receptor interacting pro tein called TRIP 13 [31] . This suggests an nNOS PDZ-mediated submembranous docking of TRIP 13 and, consequently, of the thyroid receptor that is awaiting its ligand. After ste roid binding the receptor is released from TRIP 13 and could move to the nucleus to perform its role as a transcription factor. Such a model does not unravel, however, the mecha nism by which nNOS itself is targeted to the submembranous space in brain cells. Perhaps PDZ motifs can mediate multiple interactions simultaneously, which would imply independent binding interfaces on this small protein domain.
As an alternative strategy to identify target sites for nNOS we constructed a library that directed the synthesis in yeast of constrained peptides of random sequences fused to the protein moiety encoded by the interaction trap prey vector and screened it using the nNOS PDZ motif as a bait. Oligonucleo tides were used to produce DNA fragments harboring 20 ran dom codons of the type NNB (N is any nucleotide; B is G, C, or T) flanked by BamHl and EcoR.1 sites. The codon bias was chosen in such a way that two-thirds of the encoding oligonu cleotides would lack internal stop codons. The resulting li brary contained 8 x 1 0 s individual recombinants. From 0.25X10° yeast transformants, we isolated six plasmids that encoded peptides interacting with the nNOS PDZ motif (Table  2) but not with control proteins. From these peptide sequences a C-terminal consensus target site, -G(D,E)XV*, emerged.
We next investigated the sequence specificity in the nNOS PDZ-mediated interaction in a two-hybrid assay using different baits ( Table 3 ). The nNOS PDZ motif, which has a strong affinity for the peptide GESV*, does not interact with the (T,S)XV* MAGUK target sequence as present in human Fas. The second PDZ motif of the MAGUK protein PSD-95 does bind to this hFas C-terminal peptide (Table 3 ). The same holds true for the PTP-BL PDZ motif that was reported to bind to human Fas [12] . Both PDZ motifs, however, failed to interact with the nNOS PDZ-specific peptide GESV* (Table 3) .
To look for proteins that do contain a G(D,E,N)XV* carboxyterminus and thus are prime candidates for nNOS-associated proteins, we performed a database search and identified four different types of mammalian proteins. The liver-specific nuclear protein acylneuraminate cytidylyl transferase (acc. no. P29188; carboxy-terminal sequence -GNGV*) from rat was considered not relevant on the basis of its restricted localiza tion. The other mammalian proteins were the human melano ma-associated antigen MAGE-11 (acc. no. P43364; sequence -GEGV*), the ex 1-adrenergic receptor (AR) subtype C (acc. no. P43140; sequence -GEEV*), and peptidylprolyl isomerases or cyclophilins (acc. no. S61070 and S66681; sequence -GEYV*). To test these predicted interactions a MAGE-11-encoding prey clone (available through an unrelated two-hybrid screen; W.H.A, van den Maagdenberg, B. Pepers; un published data) and the carboxyterminal tail of the rat oclC-AR were used in the interaction trap assay. Indeed we could observe a weak interaction for MAGE-11 and a strong one for cilG-AR with the nNOS PDZ motif (Table 3 ). In our search for submembranous nNOS-associating pro teins in brain we did not obtain MAGUK-encoding cDNA clones as reported by Bredt and co workers [7] . They described the binding of the second PDZ motif of PSD-95/SAP90 and of the related protein PSD-93 to amino acids 1-195 of nNOS, suggestive of PDZ-PDZ homotypic interactions. The nNOS fragment that was used in their experiment spans not only the PDZ motif (as in our study; residues 1-111) but contains an additional 87 residues C-tenninally. Thus, the observed inter actions of nNOS with PSD-95/SAP90 and PSD-93 could be mediated through binding of stretches just C-terminal of the nNOS PDZ motif, spanning residues 112-195. To investigate this possibility we generated a cDNA fragment encoding the second PDZ motif of PSD-95 by RT-PCR on brain mRNA and inserted the fragment into the interaction trap prey vec tor. Subsequently, various nNOS N-terminal fragments were produced as baits for two-hybrid analysis (Table 4 ). The ex periment showed that no interaction with PSD-95 PDZ-2 is observed for the nNOS PDZ motif alone (aa 1-111). Also, no binding with PSD-95 was found if only the additional 84 residues just C-terminal of the PDZ domain were present. By contrast, employing the entire stretch of 195 N-terminal residues of nNOS (including the PDZ motif) in the two-hybrid assay resulted in an interaction with the second PSD-95 PDZ motif (Table 4 ).
Discussion
It is becoming increasingly clear that PDZ motifs are welltailored to bind to the carboxy-termini of proteins [15, 17, 20, 32, 33] -Use of the oriented peptide library technique has resulted in a catalogue of unique optimal sequences for multiple individual PDZ motifs, defined primarily by the car boxyl terminal three to seven residues of the target peptide [34] . Using two-hybrid methodology we have identified the carboxyterminal consensus sequence that is recognized specif ically by the neuronal NOS PDZ motif (Table 2 ). This target site differs from the ones determined for mouse discs-Large, PTP-BAS, p55, LIN-2, Tiam-1, and AF-6 [34] and the (T,S)XV* peptide recognized by MAGUK family member PDZ motifs [15, 17] . Carboxyterminal sequence recognition, however, cannot explain the observed interaction between nNOS and PSD-95/SAP90 [7] and also a pure PDZ-PDZ homotypic interaction can be excluded (Table 4) . As a matter of fact, using a variety of PDZ motifs in the interaction trap assay, including those of PSD-95, nNOS and PTP-BL [19] , we have never observed any significant PDZ-PDZ association (data not shown). Nevertheless, the affinity of PSD-95 PDZ motif 2 for an nNOS internal protein segment convincingly demonstrates that PDZ-mediated interactions are not limited to C-terminal peptide recognition only.
We re-examined the clones isolated from the brain cDNA library using the nNOS PDZ motif (Table I) for the carboxyterminal sequence they encoded but this was hampered by the limited sequence data that are available for EST s. No 3' sequence entries have been deposited in the database for the EST cDNA clones 605767 and 143050. For EST clones 147773, 45462 and 530635 sequences have been determined at the 3' end (acc. nrs. R81352, H09728 and AA071113) but, provided that coding sequences are at all present in these 3' sequence segments, no G(D,E,N)XV*-like carboxyterminus was found. Also the TRIP 13 carboxyterminus (-LSLA*) lacks homology to the peptide target binding site preferred by the nNOS PDZ motif.
A database search with the preferred nNOS PDZ target site revealed three interesting candidate partner proteins; the mel anoma-associated antigen 11, cyclophilins and the alC-adrenergic receptor (Table 3 ). The human melanoma-associated antigen MAGE-11 is a member of a large family of tumor rejection antigens that are normally only expressed in testis and placenta. The cellular function of this protein class is completely obscure and, in combination with the highly re stricted expression profile, precludes a further discussion. The prototype members of the cis-trans peptidyl-prolyl isomerases, cyclophilm A and FKBP12, were discovered on the basis of their ability to bind and mediate the immunosuppres sive effects of the drugs cyclosporin, FK506 and rapamycin. Cyclophylin is localized submembranously and in brain cyclo sporin blocks the IL-2-induced release of CRH (corticotropinreleasing hormone) by preventing the dephosphorylation and thus activation of nNOS [35] * This would, however, not re quire a direct interaction between the cyclophylin carboxy-terminal tail and nNOS, and can be explained by the cyclosporin-cyclophylin complex binding to calcineurin, the calciumdependent protein phosphatase that should dephosphorylate » nNOS [36] , Finally, the a 1-adrenergic receptor (AR) subtype C is expressed in multiple tissues including brain and its carboxy terminal tail of the rat alC-AR strongly and specifically interacted with the nNOS PDZ motif (Table 3) . Interestingly, NOS is heavily involved in the regulation of hormone and neuropeptide release in different areas of the brain and is act ing downstream of the al-AR in certain signaling pathways [37, 38] . A physical link between the al-AR and NOS would be an ideal setting for such a signal cascade and, moreover, might explain why inhibition of NOS does not affect a 2-AR signal ing [39] . The interaction of the nNOS PDZ motif and the alC-AR reported here now enables to test the occurrence in vivo and, of course, to determine its functional implications.
